The Missing Ingredient: Canadian Life Sciences Industry Forecast 2013
The data gathered from this year’s respondents provides evidence of a sector showing positive signs of maturity. Yet it again highlights access to capital as the missing ingredient that will continue to limit the life sciences sector’s success. Download the report for the key findings.
Life Sciences Newsbrief – February 2013, Issue #52
Learn about PwC’s upcoming events and more in this Newsbrief edition.
Life Sciences Newsbrief – January 2013, Issue #51
In this issue, learn what challenges are on the minds of pharma and life sciences CEOs in 37 countries.
Life Sciences Newsbrief – December 2012, Issue #50
Learn about the latest thought leadership covering issues in mHealth, biotechnology and the pharma sector in India.
Life Sciences Newsbrief – November 2012, Issue #49
In this edition of the Newsbrief, learn about the latest thought leadership and events covering issues in the sector.
Life Sciences Newsbrief – October 2012, Issue #48
Participate in PwC’s Life Sciences industry forecast in this newsbrief.
Life Sciences Newsbrief – July 2012, Issue #45
In this edition of the Newsbrief, learn about PwC’s new Pharmaceuticals and Life Sciences’ leader and more.
Life Sciences Newsbrief – June 2012, Issue #44
In this edition of the Newsbrief, we have articles on biotechnology, mHealth, and more.
Life Sciences Newsbrief – May 2012, Issue #43
This issue of the Newsbrief discusses the challenges and opportunities facing medical technology companies in India, and more.
Life Sciences Newsbrief: The Penny Drops: SME Innovation Rises – 2012 Federal Budget
This special edition focuses on industry developments arising from the 2012 Canadian budgets.
Life Sciences Newsbrief – February 2012, Issue #40
Read findings from PwC’s 15th Annual Global CEO survey, Delivering results: Growth and value in a volatile world and more.
How the Jenkins report can positively shape the future of Canada’s Life Sciences Industry
The Jenkins report can become a catalyst for positive change within Canada’s life sciences sector. To ignite a consensus, our Pharmaceuticals and Life Sciences leader Gord Jans offers three suggestions.